FDA Approves Gen-Probe's PROGENSA PCA3 Assay

Gen-Probe GPRO announced today the US Food and Drug Administration (FDA) has approved its PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.